• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD - 做正确的事。

COPD - do the right thing.

机构信息

Department of Medicine, Clinical Epidemiology Division T2, Karolinska University Hospital, Karolinska Institutet, Solna, SE-171 76, Stockholm, Sweden.

Division of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

出版信息

BMC Fam Pract. 2021 Dec 11;22(1):244. doi: 10.1186/s12875-021-01583-w.

DOI:10.1186/s12875-021-01583-w
PMID:34895164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8666021/
Abstract

A gap exists between guidelines and real-world clinical practice for the management and treatment of chronic obstructive pulmonary disease (COPD). Although this has narrowed in the last decade, there is room for improvement in detection rates, treatment choices and disease monitoring. In practical terms, primary care practitioners need to become aware of the huge impact of COPD on patients, have non-judgemental views of smoking and of COPD as a chronic disease, use a holistic consultation approach and actively motivate patients to adhere to treatment.This article is based on discussions at a virtual meeting of leading Nordic experts in COPD (the authors) who were developing an educational programme for COPD primary care in the Nordic region. The article aims to describe the diagnosis and lifelong management cycle of COPD, with a strong focus on providing a hands-on, practical approach for medical professionals to optimise patient outcomes in COPD primary care.

摘要

在慢性阻塞性肺疾病(COPD)的管理和治疗方面,指南与现实临床实践之间存在差距。尽管在过去十年中,这种差距已经缩小,但在检测率、治疗选择和疾病监测方面仍有改进的空间。实际上,初级保健医生需要意识到 COPD 对患者的巨大影响,对吸烟和 COPD 作为一种慢性疾病持非评判性的观点,采用整体咨询方法,并积极激励患者坚持治疗。本文基于北欧 COPD 领域的专家(作者)在一次虚拟会议上的讨论,他们正在为北欧地区的 COPD 初级保健制定一个教育计划。本文旨在描述 COPD 的诊断和终身管理周期,重点是为医疗专业人员提供一种实用的方法,以优化 COPD 初级保健中的患者结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/fc2712c2b864/12875_2021_1583_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/fe90c9d899a3/12875_2021_1583_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/247d21e2e188/12875_2021_1583_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/b23ff223bdea/12875_2021_1583_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/016a5d70fb82/12875_2021_1583_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/fc2712c2b864/12875_2021_1583_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/fe90c9d899a3/12875_2021_1583_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/247d21e2e188/12875_2021_1583_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/b23ff223bdea/12875_2021_1583_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/016a5d70fb82/12875_2021_1583_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3153/8666021/fc2712c2b864/12875_2021_1583_Fig5_HTML.jpg

相似文献

1
COPD - do the right thing.COPD - 做正确的事。
BMC Fam Pract. 2021 Dec 11;22(1):244. doi: 10.1186/s12875-021-01583-w.
2
Guideline for the management of chronic obstructive pulmonary disease--2011 update.慢性阻塞性肺疾病管理指南——2011 年更新版。
S Afr Med J. 2011 Jan;101(1 Pt 2):63-73.
3
Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face.澳大利亚慢性阻塞性肺疾病的初始诊断与管理:一线观点
Intern Med J. 2017 Jul;47(7):807-813. doi: 10.1111/imj.13418.
4
Time pressured deprioritization of COPD in primary care: a qualitative study.初级保健中慢性阻塞性肺疾病因时间紧迫而被降低优先级:一项定性研究
Scand J Prim Health Care. 2016;34(1):55-65. doi: 10.3109/02813432.2015.1132892. Epub 2016 Feb 5.
5
Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany.德国肺病专家基于指南对门诊 COPD 管理的调查。
Int J Chron Obstruct Pulmon Dis. 2012;7:101-8. doi: 10.2147/COPD.S27887. Epub 2012 Feb 14.
6
Feasibility and impact of a computer-guided consultation on guideline-based management of COPD in general practice.计算机辅助咨询在全科医疗中对慢性阻塞性肺疾病基于指南管理的可行性及影响
Prim Care Respir J. 2012 Dec;21(4):425-30. doi: 10.4104/pcrj.2012.00088.
7
Management of chronic obstructive pulmonary disease in Swiss primary care: room for improvement.瑞士初级保健中慢性阻塞性肺疾病的管理:仍有改进空间。
Qual Prim Care. 2012;20(5):365-73.
8
Referral and consultation in asthma and COPD: an exploration of pulmonologists' views.哮喘和慢性阻塞性肺疾病的转诊与会诊:对肺科医生观点的探讨
Neth J Med. 2003 Mar;61(3):71-81.
9
COPD management by Swedish general practitioners - baseline results of the PRIMAIR study.瑞典全科医生对慢性阻塞性肺疾病的管理——PRIMAIR研究的基线结果
Scand J Prim Health Care. 2018 Mar;36(1):5-13. doi: 10.1080/02813432.2018.1426148. Epub 2018 Jan 15.
10
An overview of assessment and management in COPD.慢性阻塞性肺疾病的评估与管理概述。
Br J Community Nurs. 2009 May;14(5):195-201. doi: 10.12968/bjcn.2009.14.5.42077.

引用本文的文献

1
The Burden of COPD with Type 2 Inflammation in North-West Continental Europe.西北欧地区2型炎症相关慢性阻塞性肺疾病的负担
Int J Chron Obstruct Pulmon Dis. 2025 Aug 7;20:2767-2785. doi: 10.2147/COPD.S523371. eCollection 2025.
2
Gaylussacin, a stilbene glycoside, inhibits chronic obstructive pulmonary disease in mice.白藜芦醇苷,一种芪类糖苷,可抑制小鼠慢性阻塞性肺疾病。
Redox Biol. 2025 Jun 26;85:103744. doi: 10.1016/j.redox.2025.103744.
3
Hederasaponin C ameliorates chronic obstructive pulmonary disease pathogenesis by targeting TLR4 to inhibit NF-κB/MAPK signaling pathways.

本文引用的文献

1
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.布地奈德/格隆溴铵/富马酸福莫特罗气雾剂改善无近期加重史 COPD 患者的加重结局:KRONOS 的亚组分析。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 28;16:179-189. doi: 10.2147/COPD.S286087. eCollection 2021.
2
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.ETHOS 研究中布地奈德/格隆溴铵/福莫特罗治疗慢性阻塞性肺疾病降低全因死亡率:一项随机、双盲、多中心、平行分组研究。
Am J Respir Crit Care Med. 2021 Mar 1;203(5):553-564. doi: 10.1164/rccm.202006-2618OC.
3
常春藤皂苷元C通过靶向Toll样受体4(TLR4)抑制核因子κB(NF-κB)/丝裂原活化蛋白激酶(MAPK)信号通路来改善慢性阻塞性肺疾病的发病机制。
Chin Med. 2025 Jul 3;20(1):104. doi: 10.1186/s13020-025-01155-5.
4
Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China.慢性阻塞性肺疾病住院患者的医疗质量与结局:一项中国多中心研究
Int J Chron Obstruct Pulmon Dis. 2025 May 31;20:1787-1795. doi: 10.2147/COPD.S510613. eCollection 2025.
5
Identifying Common Diagnostic Biomarkers and Therapeutic Targets between COPD and Sepsis: A Bioinformatics and Machine Learning Approach.识别慢性阻塞性肺疾病(COPD)和脓毒症之间的常见诊断生物标志物和治疗靶点:一种生物信息学和机器学习方法。
Int J Chron Obstruct Pulmon Dis. 2025 May 28;20:1761-1786. doi: 10.2147/COPD.S510846. eCollection 2025.
6
Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action.欧洲基层医疗中的单吸入器三联疗法:专家小组关于支付方驱动的准入规则后果的共识及行动呼吁。
Int J Chron Obstruct Pulmon Dis. 2025 May 22;20:1595-1612. doi: 10.2147/COPD.S503726. eCollection 2025.
7
Association between urinary exposures and the risk of chronic obstructive pulmonary disease in smokers: results from NHANES 2007-2016.吸烟者尿液暴露与慢性阻塞性肺疾病风险之间的关联:2007 - 2016年美国国家健康与营养检查调查结果
Front Public Health. 2025 Apr 4;13:1548401. doi: 10.3389/fpubh.2025.1548401. eCollection 2025.
8
Association Between Mechanical Power and 28-Day All-Cause Mortality in Chronic Obstructive Pulmonary Disease Patients Undergoing Invasive Ventilation: Analysis of the MIMIC-IV Database.机械功率与接受有创通气的慢性阻塞性肺疾病患者28天全因死亡率之间的关联:MIMIC-IV数据库分析
Int J Chron Obstruct Pulmon Dis. 2025 Mar 24;20:785-797. doi: 10.2147/COPD.S499985. eCollection 2025.
9
Integrating network pharmacology and molecular docking to explore the pharmacological mechanism of tanshinone IIA in improving chronic obstructive pulmonary disease.整合网络药理学与分子对接技术以探究丹参酮IIA改善慢性阻塞性肺疾病的药理机制
Medicine (Baltimore). 2025 Mar 21;104(12):e41638. doi: 10.1097/MD.0000000000041638.
10
Association and risk of blood urea nitrogen-to-creatinine ratio with congestive heart failure in critically ill COPD patients.重症慢性阻塞性肺疾病(COPD)患者血尿素氮与肌酐比值与充血性心力衰竭的关联及风险
BMC Pulm Med. 2025 Mar 8;25(1):106. doi: 10.1186/s12890-025-03556-6.
Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation.首次因重度慢性阻塞性肺疾病急性加重住院患者的管理与死亡风险
Int J Chron Obstruct Pulmon Dis. 2020 Oct 28;15:2673-2682. doi: 10.2147/COPD.S276819. eCollection 2020.
4
Time for a change: anticipating the diagnosis and treatment of COPD.是时候做出改变了:预测慢性阻塞性肺疾病的诊断与治疗。
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.02104-2020. Print 2020 Jul.
5
Day and Night Control of COPD and Role of Pharmacotherapy: A Review.慢性阻塞性肺疾病的昼夜控制和药物治疗的作用:综述。
Int J Chron Obstruct Pulmon Dis. 2020 Jun 4;15:1269-1285. doi: 10.2147/COPD.S240033. eCollection 2020.
6
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.中重度至极重度 COPD 患者两种糖皮质激素剂量三联吸入治疗。
N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24.
7
Mortality of Cardiovascular Events in Patients With COPD and Preceding Hospitalization for Acute Exacerbation.COPD 患者心血管事件死亡率与急性加重期住院的关系。
Chest. 2020 Sep;158(3):973-985. doi: 10.1016/j.chest.2020.02.046. Epub 2020 Mar 14.
8
Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - Real-World Data from a Primary Care Setting.COPD 合并症及常用药物对死亡率的影响 - 初级保健环境中的真实世界数据。
Int J Chron Obstruct Pulmon Dis. 2020 Feb 3;15:235-245. doi: 10.2147/COPD.S231296. eCollection 2020.
9
Luminal Plugging on Chest CT Scan: Association With Lung Function, Quality of Life, and COPD Clinical Phenotypes.胸部 CT 扫描中的管腔堵塞:与肺功能、生活质量和 COPD 临床表型的关联。
Chest. 2020 Jul;158(1):121-130. doi: 10.1016/j.chest.2019.12.046. Epub 2020 Feb 1.
10
What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape.在开吸入药物之前需要考虑什么:评估当前吸入器领域的实用方法。
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619884532. doi: 10.1177/1753466619884532.